Silicon Laboratories, Inc. (NASDAQ:SLAB) Stock Holdings Lowered by Mutual of America Capital Management LLC

Mutual of America Capital Management LLC lowered its position in shares of Silicon Laboratories, Inc. (NASDAQ:SLAB) by 2.5% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 16,704 shares of the semiconductor company’s stock after selling 436 shares during the period. Mutual of America Capital Management LLC owned 0.05% of Silicon Laboratories worth $1,880,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. UMB Bank n.a. lifted its position in shares of Silicon Laboratories by 111.3% in the first quarter. UMB Bank n.a. now owns 336 shares of the semiconductor company’s stock worth $38,000 after purchasing an additional 177 shares in the last quarter. Parallel Advisors LLC increased its position in Silicon Laboratories by 143.7% during the first quarter. Parallel Advisors LLC now owns 463 shares of the semiconductor company’s stock worth $52,000 after acquiring an additional 273 shares during the period. Headlands Technologies LLC bought a new position in Silicon Laboratories during the fourth quarter worth $70,000. TD Private Client Wealth LLC increased its holdings in Silicon Laboratories by 53.6% in the 1st quarter. TD Private Client Wealth LLC now owns 914 shares of the semiconductor company’s stock valued at $103,000 after buying an additional 319 shares during the period. Finally, GAMMA Investing LLC increased its holdings in Silicon Laboratories by 99.6% in the 1st quarter. GAMMA Investing LLC now owns 1,126 shares of the semiconductor company’s stock valued at $127,000 after buying an additional 562 shares during the period.

Silicon Laboratories Stock Up 2.9%

NASDAQ SLAB opened at $149.63 on Friday. The company has a market cap of $4.87 billion, a price-to-earnings ratio of -29.28 and a beta of 1.47. Silicon Laboratories, Inc. has a 52 week low of $82.82 and a 52 week high of $160.00. The business has a 50 day moving average price of $136.58 and a 200-day moving average price of $127.91.

Silicon Laboratories (NASDAQ:SLAB) last posted its quarterly earnings data on Tuesday, May 13th. The semiconductor company reported ($0.08) earnings per share for the quarter, topping the consensus estimate of ($0.09) by $0.01. Silicon Laboratories had a negative return on equity of 8.80% and a negative net margin of 25.16%. The business had revenue of $177.71 million for the quarter, compared to analysts’ expectations of $177.48 million. During the same quarter in the previous year, the firm earned ($0.92) earnings per share. The business’s revenue was up 67.0% on a year-over-year basis. On average, equities research analysts anticipate that Silicon Laboratories, Inc. will post -0.97 earnings per share for the current year.

Insider Activity at Silicon Laboratories

In other Silicon Laboratories news, SVP Robert J. Conrad sold 4,029 shares of the company’s stock in a transaction dated Friday, May 16th. The stock was sold at an average price of $131.20, for a total value of $528,604.80. Following the transaction, the senior vice president directly owned 25,380 shares in the company, valued at $3,329,856. This represents a 13.70% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Robert Matthew Johnson sold 5,879 shares of the company’s stock in a transaction dated Friday, May 16th. The stock was sold at an average price of $131.20, for a total value of $771,324.80. Following the completion of the transaction, the chief executive officer owned 73,688 shares of the company’s stock, valued at $9,667,865.60. The trade was a 7.39% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 11,626 shares of company stock worth $1,509,319. 1.60% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on the stock. Stifel Nicolaus upped their price target on shares of Silicon Laboratories from $144.00 to $160.00 and gave the stock a “buy” rating in a research report on Friday. Wall Street Zen raised shares of Silicon Laboratories from a “sell” rating to a “hold” rating in a research note on Wednesday, May 14th. Barclays cut their target price on shares of Silicon Laboratories from $120.00 to $80.00 and set an “equal weight” rating for the company in a research note on Tuesday, April 22nd. KeyCorp raised their price target on Silicon Laboratories from $160.00 to $180.00 and gave the company an “overweight” rating in a report on Tuesday, July 8th. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $150.00 price target on shares of Silicon Laboratories in a report on Wednesday, May 14th. Four research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat, Silicon Laboratories currently has a consensus rating of “Moderate Buy” and a consensus target price of $134.00.

About Silicon Laboratories

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.